ANXA1 and colorectal carcinoma: Thus, increased ANXA1 expression in CRC activates the signaling cascades that promote the expression of P-gp, a transmembrane efflux pump, thereby diminishing the intracellular accumulation of 5-FU and reducing its therapeutic effectiveness [26].